Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors.
暂无分享,去创建一个
M. Tetzlaff | P. Nagarajan | D. Ivan | V. Prieto | R. Bassett | P. Aung | J. Curry | Rami N. Al-Rohil | C. Torres-Cabala | Genevieve F Lyons | R. Al-Rohil | C. Torres‐Cabala
[1] E. Nagore,et al. Predictors of Sentinel Lymph Node Status in Cutaneous Melanoma: A Classification and Regression Tree Analysis☆ , 2015 .
[2] E. Nagore,et al. Factores predictivos del estado del ganglio centinela en el melanoma cutáneo: análisis mediante un árbol de clasificación y regresión , 2015 .
[3] M. Tetzlaff,et al. Emerging clinical applications of selected biomarkers in melanoma , 2015, Clinical, cosmetic and investigational dermatology.
[4] R. Matkowski,et al. Mitotic rate is a more reliable unfavorable prognosticator than ulceration for early cutaneous melanoma: a 5-year survival analysis. , 2014, Oncology reports.
[5] N. Kolaitis,et al. Fluorescence In Situ Hybridization as an Ancillary Tool in the Diagnosis of Ambiguous Melanocytic Neoplasms: A Review of 804 Cases , 2014, The American journal of surgical pathology.
[6] M. Tetzlaff,et al. Ambiguous Melanocytic Tumors in a Tertiary Referral Center: The Contribution of Fluorescence In Situ Hybridization (FISH) to Conventional Histopathologic and Immunophenotypic Analyses , 2013, The American journal of surgical pathology.
[7] M. Ross,et al. Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma , 2013, Modern Pathology.
[8] D. Elder,et al. Risk Assessment for Atypical Spitzoid Melanocytic Neoplasms Using FISH to Identify Chromosomal Copy Number Aberrations , 2013, The American journal of surgical pathology.
[9] J. Guitart,et al. A Highly Specific and Discriminatory FISH Assay for Distinguishing Between Benign and Malignant Melanocytic Neoplasms , 2012, The American journal of surgical pathology.
[10] S. Lyle,et al. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions. , 2012, Archives of pathology & laboratory medicine.
[11] A. Rademaker,et al. Distinctive Clinical and Histologic Features in Cutaneous Melanoma With Copy Number Gains in 8q24 , 2012, The American journal of surgical pathology.
[12] J. Guitart,et al. Melanocytic Nevi With An Atypical Epithelioid Cell Component: Clinical, Histopathologic, and Fluorescence In Situ Hybridization Findings , 2011, The American journal of surgical pathology.
[13] B. Bastian,et al. Assessment of Copy Number Status of Chromosomes 6 and 11 by FISH Provides Independent Prognostic Information in Primary Melanoma , 2011, The American journal of surgical pathology.
[14] C. Shea,et al. Immunohistochemistry of melanocytic proliferations. , 2011, Archives of pathology & laboratory medicine.
[15] Patricia Switten Nielsen,et al. Immunohistochemical Double Stains Against Ki67/MART1 and HMB45/MITF: Promising Diagnostic Tools in Melanocytic Lesions , 2011, The American Journal of dermatopathology.
[16] V. Sondak,et al. Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] L. Cerroni,et al. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases , 2011, Modern Pathology.
[18] K. Busam,et al. Fluorescence in situ hybridization for distinguishing cellular blue nevi from blue nevus‐like melanoma , 2011, Journal of cutaneous pathology.
[19] J. Guitart,et al. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes. , 2010, Archives of dermatology.
[20] S. Jhanwar,et al. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization , 2010, Journal of cutaneous pathology.
[21] N. Kolaitis,et al. Use of Fluorescence In situ Hybridization (FISH) to Distinguish Intranodal Nevus From Metastatic Melanoma , 2010, The American journal of surgical pathology.
[22] Yu Fang,et al. Fluorescence in Situ Hybridization for Distinguishing Nevoid Melanomas From Mitotically Active Nevi , 2009, The American journal of surgical pathology.
[23] L. Morrison,et al. Fluorescence In Situ Hybridization (FISH) as an Ancillary Diagnostic Tool in the Diagnosis of Melanoma , 2009, The American journal of surgical pathology.
[24] R. Vollmer,et al. Mitotic rate in melanoma: a reexamination. , 2007, American journal of clinical pathology.
[25] B. Gonçalves,et al. Expression of Ki‐67, Topoisomerase IIα and c‐MYC in astrocytic tumors: Correlation with the histopathological grade and proliferative status , 2006, Neuropathology : official journal of the Japanese Society of Neuropathology.
[26] B. Diffey,et al. Climate change, ozone depletion and the impact on ultraviolet exposure of human skin. , 2004, Physics in medicine and biology.
[27] Daniel Pinkel,et al. Classifying melanocytic tumors based on DNA copy number changes. , 2003, The American journal of pathology.
[28] J. Naeyaert,et al. Inter‐observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions , 2002, The Journal of pathology.
[29] D. Pinkel,et al. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. , 1998, Cancer research.
[30] R. Parwaresch,et al. Diagnostic assessment of two novel proliferation-specific antigens in benign and malignant melanocytic lesions. , 1995, The American journal of pathology.
[31] E. Nagore,et al. Predictors of sentinel lymph node status in cutaneous melanoma: a classification and regression tree analysis. , 2015, Actas dermo-sifiliograficas.
[32] T. Milman. Update on Fluorescence In Situ Hybridization in Melanoma: State of the Art , 2012 .
[33] S. Purcell. Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up , 2011 .
[34] Gao Hai-feng,et al. Proliferation marker Ki-67 in early breast cancer , 2009 .
[35] P. G. Lang,et al. Skin Biopsy Rates and Incidence of Melanoma: Population Based Ecological Study , 2006 .